Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney

Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney

Introduction We present a case of urothelial carcinoma in a renal allograft successfully treated with pembrolizumab. Case presentation A 39‐year‐old woman presented with nausea and anorexia 9 years after a renal transplantation. Positron emission tomography revealed a neoplasm of the renal pelvis of...

Full description

Bibliographic Details
Main Authors: Jun Kamei, Hirotaka Yokoyama, Toshiro Niki, Ryosuke Suda, Toru Sugihara, Akira Fujisaki, Satoshi Ando, Daiki Iwami, Tetsuya Fujimura
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:IJU Case Reports
Subjects:
immune checkpoint inhibitor
kidney transplantation
pembrolizumab
transplant rejection
urothelial carcinoma
Online Access:https://doi.org/10.1002/iju5.12438

Internet

https://doi.org/10.1002/iju5.12438

Similar Items